Pulse Biosciences Inc reports results for the quarter ended in September - Earnings Summary

Pulse Biosciences

16/11/2021 24:11

* Pulse Biosciences Inc  PLSE.OQ  reported a quarterly adjusted
loss of 48 cents​​ per share for the quarter ended in September.
The mean expectation of three analysts for the quarter was for a
loss of 53 cents per share.
* Revenue was $574.00 thousand​;  analysts expected $188.67
thousand. 
* Pulse Biosciences Inc's reported EPS for the quarter was a
loss of 48 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Pulse Biosciences Inc shares had risen by 0.1% this
quarter and lost 9.3% so far this year.
* The company reported a quarterly loss of $14.28 million.
* Wall Street's median 12-month price target for Pulse
Biosciences Inc is $40.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 16 at 12:11 a.m.
 ​All figures in US dollars unless otherwise stated